Low-grade inflammation from prenatal period to age 6-8 years in a Vitamin D trial

Helena H Hauta-Alus1,2,3,4, Jenni Rosendahl5,6, Elisa M Holmlund-Suila5,6

  • 1Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. helena.hauta-alus@helsinki.fi.

Pediatric Research
|January 15, 2024
PubMed

Insights

Childhood inflammation, measured by high sensitivity C-reactive protein (hs-CRP), persists from birth to age 8. Higher vitamin D levels, not dose, correlated with increased hs-CRP in children, suggesting early inflammation impacts long-term health.

Area of Science:

  • Pediatric Health
  • Inflammation Biomarkers
  • Nutritional Immunology

Background:

  • Low-grade systemic inflammation, indicated by high sensitivity C-reactive protein (hs-CRP), is linked to non-communicable disease risk.
  • Prenatal inflammation and early-childhood vitamin D status may influence persistent inflammation in children.

Purpose of the Study:

  • To investigate the association between prenatal inflammation and early-childhood vitamin D levels with inflammation markers until age 6-8 years.
  • To determine the persistence of inflammation from birth through early childhood.

Main Methods:

  • Analysis of blood hs-CRP and 25-hydroxy vitamin D [25(OH)D] in pregnant women, umbilical cord blood (UCB), and offspring at ages 1, 2, and 6-8 years.
  • Utilized data from the Vitamin D Intervention in Infants (VIDI) randomized-controlled trial, including vitamin D supplementation arms.

Main Results:

  • Higher UCB hs-CRP was independently associated with elevated hs-CRP levels persisting until age 6-8 years.
  • Infant vitamin D supplementation dose did not impact longitudinal hs-CRP levels.
  • Increased childhood 25(OH)D concentrations showed a positive association with hs-CRP up to age 6-8 years.

Conclusions:

  • Childhood inflammation, assessed by hs-CRP, demonstrates persistence from birth to age 8.
  • A positive association exists between vitamin D sufficiency and hs-CRP levels in children.
  • Chronic disease risk stemming from inflammation may originate in the prenatal period or early childhood.
Abstract